COVID-19伴神经系统症状患者的脑脊液生物标志物:病例系列
该病例系列纳入6例有神经系统症状的中重度COVID-19住院患者,进行诊断性腰椎穿刺,检测脑脊液SARS-CoV-2 RNA及炎症、血脑屏障和轴索损伤标志物。结果显示脑脊液新蝶呤和β2微球蛋白均升高,但白细胞计数、IgG指数和白蛋白比值正常,仅2例NfL升高,SARS-CoV-2 RNA检测不稳定。提示COVID-19脑脊液呈可溶性炎症标志物升高而细胞反应缺如的不寻常模式。
要点
- COVID-19伴神经系统症状患者脑脊液新蝶呤和β2微球蛋白普遍升高。
- 脑脊液白细胞计数、IgG指数和白蛋白比值多正常,缺乏典型病毒性中枢感染特征。
- 脑脊液SARS-CoV-2 RNA检测不稳定,不能确证病毒直接入侵中枢。
核心结论
- COVID-19伴神经系统症状患者脑脊液呈可溶性炎症标志物升高而白细胞反应缺如的不寻常模式,不能确证SARS-CoV-2直接驱动中枢炎症。
研究设计与样本
- 病例系列纳入6例有神经系统症状的中重度COVID-19住院患者,均行诊断性腰椎穿刺,检测脑脊液SARS-CoV-2 RNA及炎症、血脑屏障和轴索损伤标志物。
主要发现
- 脑脊液新蝶呤中位数43.0 nmol/L和β2微球蛋白中位数3.1 mg/L在所有患者中均升高。
- 脑脊液IgG指数中位数0.39、白蛋白比值中位数5.35和白细胞计数<3 cells/µL在所有患者中均正常。
- 脑脊液NfL在2例患者中升高。
- 2例患者血浆SARS-CoV-2 RNA阳性(Ct 35.0-37.0),3例脑脊液低水平阳性(Ct 37.2、38.0、39.0)但仅一次实时PCR检出。
临床怎么用
- 对COVID-19伴神经系统症状患者,脑脊液可溶性炎症标志物升高而细胞数正常时,不应简单按典型病毒性中枢感染解释。
局限性
- 样本量仅6例,脑脊液SARS-CoV-2 RNA检测结果不稳定,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore whether hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and neurologic symptoms have evidence of CNS infection, inflammation, and injury using CSF biomarker measurements. METHODS: We assessed CSF SARS-CoV-2 RNA along with CSF biomarkers of intrathecal inflammation (CSF white blood cell count, neopterin, β2-microglobulin, and immunoglobulin G index), blood-brain barrier integrity (albumin ratio), and axonal injury (CSF neurofilament light chain protein [NfL]) in 6 patients with moderate to severe coronavirus disease 2019 (COVID-19) and neurologic symptoms who had undergone a diagnostic lumbar puncture. Neurologic symptoms and signs included features of encephalopathies (4 of 6), suspected meningitis (1 of 6), and dysgeusia (1 of 6). SARS-CoV-2 infection was confirmed by real-time PCR analysis of nasopharyngeal swabs. RESULTS: SARS-CoV-2 RNA was detected in the plasma of 2 patients (cycle threshold [Ct] value 35.0-37.0) and in CSF at low levels (Ct 37.2, 38.0, 39.0) in 3 patients in 1 but not in a second real-time PCR assay. CSF neopterin (median 43.0 nmol/L) and β2-microglobulin (median 3.1 mg/L) were increased in all. Median immunoglobulin G index (0.39), albumin ratio (5.35), and CSF white blood cell count (<3 cells/µL) were normal in all, while CSF NfL was elevated in 2 patients. CONCLUSION: Our results in patients with COVID-19 and neurologic symptoms suggest an unusual pattern of marked CSF inflammation in which soluble markers were increased but white cell response and other immunologic features typical of CNS viral infections were absent. While our initial hypothesis centered on CNS SARS-CoV-2 invasion, we could not convincingly detect SARS-CoV-2 as the underlying driver of CNS inflammation. These features distinguish COVID-19 CSF from other viral CNS infections and raise fundamental questions about the CNS pathobiology of SARS-CoV-2 infection.
引用
- Edén A, Kanberg N, Gostner J, et al. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series. Neurology. 2020. PMID: 33004602. doi:10.1212/WNL.0000000000010977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。